Search research articles
Contact Us
Filters
Showing results (71-80 of 103) with videos related to
Page
of 11
Sort By:
Bone Marrow Transplantation
|
May 21, 2013
Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR
F V Michelis, E G Atenafu, V Gupta, et al.
The Pharmacogenomics Journal
|
September 24, 2014
ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis
Q Zheng, H Wu, Q Yu, et al.
Leukemia Research
|
December 4, 2014
Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors
J H Lipton, P Bryden, M K Sidhu, et al.
Bone Marrow Transplantation
|
August 12, 2014
The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD
J Uhm, N Hamad, F V Michelis, et al.
Blood Cancer Journal
|
December 15, 2015
Prediction of response and survival in patients with chronic-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate: logistic regression and landmark analyses
M Wetzler, H M Kantarjian, F E Nicolini, et al.
Bone Marrow Transplantation
|
November 17, 2009
Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR
R Kohli, W Xu, J Brandwein, et al.
Bone Marrow Transplantation
|
July 1, 2014
Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning
M Shanavas, H A Messner, E G Atenafu, et al.
Bone Marrow Transplantation
|
March 17, 2015
Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD
N Alam, W Xu, E G Atenafu, et al.
Leukemia
|
June 30, 2015
BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase
T P Hughes, G Saglio, A Quintás-Cardama, et al.
Bone Marrow Transplantation
|
February 21, 2017
A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient
C Bourlon, S Alamoudi, D Kumar, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 103) with videos related to
Sort By:
Page
of 11
Bone Marrow Transplantation
|
May 21, 2013
Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR
F V Michelis, E G Atenafu, V Gupta, et al.
The Pharmacogenomics Journal
|
September 24, 2014
ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis
Q Zheng, H Wu, Q Yu, et al.
Leukemia Research
|
December 4, 2014
Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors
J H Lipton, P Bryden, M K Sidhu, et al.
Bone Marrow Transplantation
|
August 12, 2014
The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD
J Uhm, N Hamad, F V Michelis, et al.
Blood Cancer Journal
|
December 15, 2015
Prediction of response and survival in patients with chronic-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate: logistic regression and landmark analyses
M Wetzler, H M Kantarjian, F E Nicolini, et al.
Bone Marrow Transplantation
|
November 17, 2009
Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR
R Kohli, W Xu, J Brandwein, et al.
Bone Marrow Transplantation
|
July 1, 2014
Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning
M Shanavas, H A Messner, E G Atenafu, et al.
Bone Marrow Transplantation
|
March 17, 2015
Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD
N Alam, W Xu, E G Atenafu, et al.
Leukemia
|
June 30, 2015
BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase
T P Hughes, G Saglio, A Quintás-Cardama, et al.
Bone Marrow Transplantation
|
February 21, 2017
A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient
C Bourlon, S Alamoudi, D Kumar, et al.
Page
of 11